Bone delivery system having a therapeutic agent
A covering for delivering a therapeutic agent to a surgical site is provided. The covering may include a single or multi-compartment structure configured to at least partially retain the therapeutic agent until the covering is placed at a surgical site. Upon placement, the covering may facilitate transfer of the therapeutic agent to the surgical site. In some embodiments, the covering comprises an antimicrobial agent, a hemostatic agent, an anti-inflammatory agent, and/or a growth factor.
1. A delivery system comprising: a covering configured for implantation into a bone defect site and comprising one or more polymers, the covering being porous and comprising at least one compartment; a demineralized bone matrix material comprising fully demineralized bone matrix fibers and surface demineralized bone chips in a ratio of about 25:75 to about 75:25 disposed within the at least one compartment, wherein the covering retains the demineralized bone matrix material for placement at the bone defect site and facilitates transfer of cells into and out of the covering and the covering comprises a therapeutic agent disposed within the at least one compartment or on a surface of the covering, and the covering comprises edges comprising a polymer that is different and more hydrophilic than the at least one or more polymers of the rest of the covering.
2. A delivery system of claim 1 , wherein the therapeutic agent comprises an antimicrobial agent, a hemostatic agent, an anti-inflammatory agent, and/or a growth factor that is disposed on or in front and back surfaces of the covering.
3. A delivery system of claim 2 , wherein the antimicrobial agent comprises chitosan and silver.
4. A delivery system of claim 2 , wherein the hemostatic agent comprises collagen particles.
5. A delivery system of claim 1 , wherein the covering includes at least one separation-assist line and the at least one separation-assist line comprises a score line.
6. A delivery system of claim 1 , comprising a plurality of separation-assist lines defined in the covering, the separation-assist lines configured to facilitate separation of the delivery system into a plurality of pieces.
7. A delivery system of claim 1 , wherein the covering comprises human skin, collagen, human hair, polyethylene glycol, chitosan, alginate, cellulose, hyaluronic acid, poly(lactide-co-glycolide), fat, bone, or a combination thereof.
8. A delivery system of claim 1 , wherein the covering comprises a modulus of elasticity of about 1×10 2 to about 6×10 5 dynes/cm 2 before placement at the bone defect site, and a modulus of elasticity of 1×10 2 to about 6×10 5 dynes/cm 2 after placement at the bone defect site.
9. A delivery system for placement in a bone defect site, the delivery system comprising: a biodegradable covering comprising a polymer, the covering comprising at least one compartment and at least one separation-assist line; and a demineralized bone matrix material comprising fully demineralized bone matrix fibers and surface demineralized bone chips in a ratio of about 25:75 to about 75:25 and a therapeutic agent disposed within the at least one compartment, wherein the covering retains the demineralized bone matrix material for placement at the bone defect site and facilitates transfer of cells into and out of the covering, and the covering comprises edges comprising a polymer that is different and more hydrophilic than the polymer of the rest of the covering.
10. A delivery system of claim 9 , wherein the at least one separation-assist line comprises a score line.
11. A delivery system of claim 10 , comprising a plurality of separation-assist lines defined in the covering, the separation-assist lines configured to facilitate separation of the delivery system into a plurality of pieces.
12. A delivery system of claim 9 , wherein the therapeutic agent comprises an antimicrobial agent, a hemostatic agent, an anti-inflammatory agent, and/or a growth factor.
13. A delivery system of claim 12 , wherein the covering comprises chitosan and silver and/or the hemostatic agent comprises collagen particles.
14. A method for treating a bone defect in a patient in need of such treatment, the method comprising: implanting into the bone defect all or at least a portion of a covering comprising one or more biodegradable polymers, the covering being porous and comprising at least one compartment, and a demineralized bone matrix material comprising fully demineralized bone matrix fibers and surface demineralized bone chips in a ratio of about 25:75 to about 75:25 and a therapeutic agent disposed within the at least one compartment, wherein the covering retains the demineralized bone matrix material at, near, or in the bone defect and facilitates transfer of cells into and out of the covering, and the covering comprises edges comprising a polymer that is different and more hydrophilic than the at least one or more polymers of the rest of the covering.
15. A method for treating a bone defect according to claim 14 , wherein the implanting comprises (i) applying force to the covering along a separation assist line to pull apart a portion of the covering and implant the covering at, near or in the bone defect; or (ii) sealing edges of the covering containing the demineralized bone matrix material before the covering is implanted at, near or in the bone defect.
16. A method for treating a bone defect according to claim 14 , wherein the implanting comprises folding the covering over itself and implanting the covering at, near or in the bone defect.